Supernus Pharmaceuticals (SUPN)

Supernus Pharmaceuticals (SUPN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• SUPN last traded at $41.92, 0.19% on the day.
• Supernus Pharmaceuticals: market cap $2.44B, P/E -55.1, revenue $865.11M over the last four quarters.
• Over the past year SUPN returned -25.81%; year to date -15.65%.

Updated 2026-11-02 17:49 UTC